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ABSTRAK
Penyembuhan luka merupakan kerja sama antara berbagai macam sel, faktor pertumbuhan dan protein 
matrik ekstrasel. Inti dari proses ini adalah mesenkimal stem cell (MSCs) endogen, yang mengkoordinasi 
perbaikan, dengan mengaktifkan sel host dan mensekresi berbagai macam faktor pertumbuhan dan protein 
matrik. MSCs adalah sel yang mampu memperbaharui dinya sendiri serta mampu melakukan transdiferensiasi 
pada galur sel-sel lain seprti, tulang, tulang rawan, tendo dan lemak. MSCs mengatur reaksi umun, inflamasi, 
dan mempunyai kemampuan yang tinggi untuk melindungi dan meregenerasi jaringan tubuh yang terluka, 
membuat sel tersebut mampu menatraktif untuk pengobatan berbagai macam penyakit. Manfaat efek MSCs 
eksogen telah dilaporkan pada berbagai penelitian dengan meggunakan hewan coba, untuk penyembuhan 
luka, dengan hasil yang memuaskan terutama pada luka kronis dengan menstimulasi penyembuhan luka secara 
cepat. Telah banyak produk yang digunakan untuk penyembuhan luka kronis, tetapi belum dapat menghasilkan 
penyembuhan secara maksimal. Dalam laporan ini, akan dilaporkan peranan MSCs eksogen pada luka kronis, 
dengan ilustrasi laporan ulkus kronis, serta didiskusikan peranan MSCs pada tahap-tahap penyembuhan luka.
Kata kunci: mesenkimal stem cells, secretomes, regenerasi jaringan, ulkus kronis.
ABSTRACT
Wound healing requires a coordinated interplay among cells, growth factors, and extracellular matrix 
proteins. Central to this process is the endogenous mesenchymal stem cell (MSC), which coordinates the repair 
response by recruiting other host cells and secreting growth factors and matrix proteins. MSCs are self-renewing 
multipotent stem cells that can differentiate into various lineages of mesenchymal origin such as bone, cartilage, 
tendon, and fat. In addition to multilineage differentiation capacity, MSCs regulate immune response and 
inflammation and possess powerful tissue protective and reparative mechanisms, making these cells attractive 
for treatment of different diseases. The beneficial effect of exogenous MSCs on wound healing was observed 
in a variety of animal models and in reported clinical cases. Specifically, they have been successfully used to 
treat chronic wounds and stimulate stalled healing processes. Recent studies revealed that human placental 
membranes are a rich source of MSCs for tissue regeneration and repair. This review provides a concise summary 
of current knowledge of biological properties of MSCs and describes the use of MSCs for wound healing. In 
particular, the scope of this review focuses on the role MSCs have in each phase of the wound-healing process, 
and clinical reports transplatation MSCs – secretomes in chronical ulcer.
Keywords: mesenchymal stem cells, secretomes, tissue regeneration, chronical ulcer.
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INTRODUCTION
Nonhealing chronic wounds are a large 
and growing problem with an incidence of 
5–7 million cases per year in the United 
States, and 50% of those wounds do not 
respond to current treatments. Accumulated data 
indicate that wound-care products should have 
a composition equivalent to that of the skin: a 
combination of particular growth factors and 
extra cellular matrix (ECM) proteins endogenous 
to the skin, together with viable epithelial cells, 
fibroblasts, and mesenchymal stem cells (MSCs). 
Recently, strategies consisting of bioengineered 
dressings and cell-based products have emerged 
for widespread clinical use; however, their 
performance is not optimal because chronic 
wounds persist as a serious unmet medical need. 
The presence of MSCs in normal skin and their 
critical role in wound healing suggest that the 
application of exogenous MSCs is a promising 
solution to treat nonhealing wounds.1,2
MSCs have been well characterized to be 
multipotent cells that can differentiate into 
multiple tissue-forming cell lineages, such as 
osteoblasts, adipocytes, chondrocytes, tenocytes, 
and myocytes. In addition, they can be readily 
expanded ex vivo for several passages without 
losing their self-renewal capacity. In addition to 
the multilineage differentiation capacity that is 
useful for regeneration, MSCs regulate immune 
and inflammatory responses. These functions 
provide therapeutic potential for treating 
conditions characterized by the presence of an 
inflammatory component. MSCs can also have 
a reparative effect through paracrine signaling 
by releasing biologically active molecules that 
affect cell migration, proliferation, and survival 
of the surrounding cells.
The involvement of MSCs in the wound-
healing process is critical, in particular for 
difficult nonhealing wounds resulting from 
trauma, diabetes, vascular insufficiency, and 
numerous other conditions. MSCs have a role in 
the inflammatory, proliferative, and remodeling 
phases of wound healing, and their presence 
supports healthy physiologic functioning 
towards successful healing. As such, therapeutic 
application of MSCs has been shown to enhance 
and improve wound healing in clinical settings.1
CASE ILLUSTRATION
A patient, male, aged 33 years old, with a 
complaint an fistula in peri-anal (dextra) area. He 
has surgeries as many as 7 times during aperiode 
of 3 months, but the ulcers got worst, and there 
was no cure and even the pain followed. The 
Figure 1 shows a tamponade supporting the deep 
and wide ulcer and was always replaced every 2 
days in the hospital.
Figure 1. A tamponade supporting the deep and wide ulcer
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The size of the wound was quite big and it 
did not heal, indeed. Intracutaneous injection 
and tropical application of antibiotc gel + MSCs-
secretomes were provided around the ulcer 
followed by occlusived bandage.
After 4 days, fistula healed and it was confirm 
when author cheked by no 14 labeled needle 
insertion, it turned out some pain, giving a clue 
that there was some tissues growing.
DISCUSSION
MSCs are involved in all three phases of 
wound healing to varying degrees. They also 
influence the wound’s ability to progress beyond 
the inflammatory phase and not regress to a 
chronic wound state. A significant component 
of the mechanism of action of MSCs is that 
they directly attenuate inflammatory response. 
Studies have shown that the addition of MSCs to 
an active immune response decreases secretion 
of the proinflammatory cytokines TNF-α and 
interferon-γ (IFN-γ) while simultaneously 
increasing the production of anti-inflammatory 
cytokines interleukin-10 (IL-10) and IL-4.3,4 It 
is these anti-inflammatory properties of MSCs 
that make them particularly beneficial to chronic 
wound treatment, as they can restart healing 
in stalled wounds by advancing the wound 
past a chronic inflammatory state into the next 
stage of healing. Accumulated data indicate 
the importance of MSC anti-inflammatory and 
immunomodulative activities in wound healing.
At the present time it is recognized that 
MSCs have antimicrobial activity, which is 
critical for wound clearance from infection. 
MSC antimicrobial activity is mediated by 
two mechanisms: direct, via secretion of 
antimicrobial factors such as LL-375, and 
indirect, via secretion of immune-modulative 
factors, which will upregulate bacterial killing 
and phagocytosis by immune cells.2
MSCs in vivo can migrate to sites of injury 
in response to chemotactic signals modulating 
inflammation, repairing damaged tissue, and 
facilitating tissue regeneration . Differentiation 
and paracrine signaling have both been implicated 
as mechanisms by which MSCs improve tissue 
repair. MSC differentiation contributes by 
regenerating damaged tissue, whereas MSC 
paracrine signaling regulates the local cellular 
responses to injury. Current data suggest that the 
contribution of MSC differentiation is limited 
due to poor engraftment and survival of MSCs 
at the site of injury. MSC paracrine signaling is 
likely the primary mechanism for the beneficial 
effects of MSCs on wounds, that is, to reduce 
inflammation, promote angiogenesis, and induce 
cell migration and proliferation.6
Analyses of MSC-conditioned medium 
indicate that MSCs secrete many known 
mediators of tissue repair including growth 
factors, cytokines, and chemokines, specifically 
VEGF, PDGF, bFGF, EGF, keratinocyte growth 
factor (KGF), and TGF-β.6,7 Studies indicate 
that many cell types, including epithelial cells, 
endothelial cells, keratinocytes, and fibroblasts, 
are responsive to MSC paracrine signaling, 
which regulates a number of different cellular 
responses including cell survival, proliferation, 
migration, and gene expression.7
MSC-conditioned medium acts as a 
chemoattractant for macrophages, endothelial 
cells, epidermal keratinocytes, and dermal 
fibroblasts in vitro. The presence of either MSCs 
or MSC-conditioned medium has been shown 
to promote dermal fibroblasts to accelerate 
wound closure. MSCs also secrete mitogens that 
stimulate proliferation of keratinocytes, dermal 
fibroblasts, and endothelial cells in vitro. Further 
investigation has shown that dermal fibroblasts 
secrete increased amounts of collagen type I 
and alter gene expression in response to either 
MSCs in coculture or MSC-conditioned medium. 
Overall, these data suggest that MSCs release 
soluble factors that stimulate proliferation and 
migration of the predominant cell types in the 
wound. In addition, the paracrine signaling of 
MSCs provides antiscarring properties through 
the secretion of VEGF and hepatocyte growth 
factor (HGF) and maintaining the proper balance 
between TGF-β1 and TGF-β3.6,8
Evidence of MSC Importance in Healing
In vivo studies have also demonstrated 
the advantages of using exogenous MSCs for 
the treatment of wounds. Several studies have 
shown that the administration of MSCs to either 
acute or diabetic wounds in rodents improves 
wound closure by accelerating epithelialization, 
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increasing granulation tissue formation, and 
increasing angiogenesis. Nakagawa et al.9 
suggested that MSCs, together with bFGF in a 
skin defect model, accelerate wound healing and 
showed that the human MSCs transdifferentiated 
into the epithelium in rats. Shumakov et al.10 
showed that the transplantation of MSCs on the 
surface of deep burn wounds in rats decreased 
inflammatory cell infiltration and accelerated 
the formation of new vessels and granulation 
tissue. The cells were also shown to produce 
bioactive substances that seemed to accelerate 
the regeneration process. Collectively, these 
data demonstrate that MSC treatment impacts all 
phases of wound repair, including inflammation, 
epithelialization, granulation tissue formation, 
and tissue remodeling.9,10
CONCLUSION
Wound healing is a complex process that 
requires the coordinated interplay of ECM, 
growth factors, and cells. MSCs, in particular, 
play an important role in mediating each phase 
of the wound-healing process—inflammatory, 
proliferative, and remodeling. During the 
inflammatory phase, MSCs coordinate the 
effects of inflammatory cells and inhibit the 
deleterious effects of inflammatory cytokines 
such as TNF and IFN-γ. In addition, MSCs 
support wound clearance from infection via 
direct secretion of antimicrobial factors and 
by stimulating phagocytosis by immune cells. 
The ability of MSCs to promote the transition 
from the inflammatory to the proliferative 
phase is particularly critical for treating chronic 
wounds where high levels of inflammation 
prevent healing. MSCs also contribute to the 
proliferative phase by expressing growth factors 
such as VEGF, bFGF, and KGF to promote 
granulation and epithelialization. Lastly, MSCs 
regulate remodeling of the healed wound by 
promoting organized ECM deposition. As such, 
the benefits of MSCs in wound healing have 
been demonstrated in several preclinical and 
clinical studies. Thus, multiple mechanisms 
are involved in MSC-mediated wound healing, 
including antiinflammatory and antimicrobial, 
immunomodulative, and tissue reparative 
activities.
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